Phage Therapy Breakthrough

The conversation highlights the growing interest in phage therapy as a solution to antibiotic resistance, driven by compelling patient cases and increasing academic support. Steffanie shares insights on the shift in perception among doctors and the involvement of pharmaceutical companies, emphasizing the need for clinical trials to validate phage therapy's efficacy. She dreams of creating an open-source phage bank to make this treatment accessible globally, particularly for those in lower-income regions suffering from superbugs.